Last reviewed · How we verify

NCT04318106

Reading; Through the Eyes of a University Student

Completed NA Last updated 19 February 2026
What this trial tests

NA trial testing Precision tinted spectacle lenses in Visual Stress in 72 participants. Completed in 30 June 2025.

Timeline
27 January 2020
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorUniversity of Ulster
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment72
Start date27 January 2020
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Ulster

Who can join

Adults 18 to 45, any sex, with Visual Stress or Meares-Irlen Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a double-masked randomized controlled trial which aims to assess the effects of precision tinted spectacle lenses on visual stress symptoms within an undergraduate University student population.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Reading through the eyes of a university student: A double-masked randomised placebo-controlled cross-over protocol investigating coloured spectacle lens efficacy in adults with visual stress.
    Harkin DL, Little JA, McCullough SJ. · · 2025 · cited 1× · PMID 40587476 · DOI 10.1371/journal.pone.0309625
  2. Reading; through the eyes of a university student: A double-masked randomised placebo-controlled cross-over protocol investigating coloured spectacle lens efficacy in adults with visual stress.
    Harkin DL, Little J, McCullough SJ. · · 2024 · DOI 10.1101/2024.08.18.24312188

Verify or expand the search:

Other University of Ulster trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04318106.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing